Lobby organisation
Abbott
Company · Health & pharma · HQ: United States · Transparency Register entry
As of 7 November 2026, Abbott appears in 9 declared MEP meetings (7 different MEPs), most often with European People's Party.
In their own words
“Abbott is a global leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 9 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2024–2026. Bar length is relative to its busiest year (7 in 2026). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 9 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 20 Oct 2026 | Diego Solier | Exchange of Views |
| 20 Oct 2026 | Tiemo Wölken | MDR/IVDR Revision and Biotech Act |
| 25 Jun 2026 | Ondřej Knotek | Medical Devices Regulation |
| 23 Jun 2026 | Cynthia Ní Mhurchú | Medical Devices |
| 23 Jun 2026 | András Tivadar Kulja | MDR |
| 23 Jun 2026 | Andreas Glück | MDR IVDR Revision |
| 28 Apr 2026 | Ingeborg ter Laak | Biotech Act |
| 4 Jun 2025 | András Tivadar Kulja | European Healthcare |
| 12 Feb 2024 | Andreas Glück | Import von tierischen Nebenprodukten für Arzneimittelherstellung |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.